ARIUS Research Inc. (TSX-VE: ARI) announced today that it will present a number of new therapeutic anti-cancer antibody programs at the 97th Annual Meeting of the American Association for Cancer Research in Washington, D.C., from April 1-5, 2006. The antibodies were generated using ARIUS’ FunctionFIRST(TM) platform.
